Monsanto Company (MON) : Walter Keenan Financial Consulting Co Mi Adv reduced its stake in Monsanto Company by 7.77% during the most recent quarter end. The investment management company now holds a total of 9,500 shares of Monsanto Company which is valued at $999,875 after selling 800 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Monsanto Company makes up approximately 0.28% of Walter Keenan Financial Consulting Co Mi Adv’s portfolio.
Other Hedge Funds, Including , Cwa Asset Management Group added MON to its portfolio by purchasing 8,155 company shares during the most recent quarter which is valued at $858,314. Monsanto Company makes up approx 0.50% of Cwa Asset Management Group’s portfolio.Quest Investment Management Incor reduced its stake in MON by selling 12,644 shares or 19.61% in the most recent quarter. The Hedge Fund company now holds 51,838 shares of MON which is valued at $5,455,950. Monsanto Company makes up approx 0.75% of Quest Investment Management Incor’s portfolio.Columbia Partners L L C Investment Management reduced its stake in MON by selling 44,267 shares or 45.28% in the most recent quarter. The Hedge Fund company now holds 53,498 shares of MON which is valued at $5,630,665. Monsanto Company makes up approx 0.40% of Columbia Partners L L C Investment Management’s portfolio. Somerville Kurt F sold out all of its stake in MON during the most recent quarter. The investment firm sold 3,825 shares of MON which is valued $405,144. Argent Capital Management added MON to its portfolio by purchasing 2,000 company shares during the most recent quarter which is valued at $211,840. Monsanto Company makes up approx 0.01% of Argent Capital Management’s portfolio.
Monsanto Company opened for trading at $106.77 and hit $106.95 on the upside on Wednesday, eventually ending the session at $106.57, with a gain of 0.47% or 0.5 points. The heightened volatility saw the trading volume jump to 3,063,598 shares. Company has a market cap of $46,632 M.
On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.
Investors should note that on Aug 12, 2016, Monsanto Company announced a cash dividend of $0.5400. The company’s management has announced Oct 5, 2016 as the ex-dividend date and fixed the record date on Oct 7, 2016. The payable date has been fixed on Oct 28, 2016.
Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.
Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.